Exon David J, Sydney Chung S C
Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China.
Best Pract Res Clin Gastroenterol. 2004 Feb;18(1):77-98. doi: 10.1016/S1521-6918(03)00102-1.
Upper gastrointestinal bleeding (UGIB) is one of the most common medical emergencies and remains a major cause of morbidity and mortality among patients. Although initially employed diagnostically, endoscopy has steadily replaced surgery as a first-line treatment in all but the haemodynamically unstable patient. A vast selection of techniques and devices are now available to the dedicated therapeutic endoscopist, including injection therapy, electrical or thermal coagulation and mechanical banding or clipping. The use of endoscopic ultrasound for targeting treatment is increasing and the development of new technologies, such as capsule endoscopy, is likely to play an important role in future protocols. However, despite numerous randomized controlled trials and meta-analyses comparing the efficacy of different endoscopic interventions, the implementation of obtained results into treatment regimes has so far failed to impact significantly on overall UGIB mortality, which remains stubbornly at 10-14%. Reducing this continues to be one of the main challenges facing the therapeutic endoscopist.
上消化道出血(UGIB)是最常见的内科急症之一,仍是患者发病和死亡的主要原因。尽管内镜检查最初用于诊断,但除血流动力学不稳定的患者外,它已逐渐取代手术成为一线治疗方法。现在,专业的治疗内镜医师可以使用多种技术和设备,包括注射治疗、电凝或热凝以及机械套扎或钳夹。内镜超声用于靶向治疗的应用正在增加,新技术如胶囊内镜的发展可能在未来的治疗方案中发挥重要作用。然而,尽管有众多随机对照试验和荟萃分析比较了不同内镜干预措施的疗效,但将所得结果应用于治疗方案迄今尚未对UGIB的总体死亡率产生显著影响,该死亡率仍顽固地维持在10% - 14%。降低这一死亡率仍然是治疗内镜医师面临的主要挑战之一。